These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24597702)

  • 1. A novel accelerated in vitro release method to evaluate the release of thymopentin from PLGA microspheres.
    Xie X; Li Z; Zhang L; Chi Q; Yang Y; Zhang H; Yang Y; Mei X
    Pharm Dev Technol; 2015; 20(5):633-40. PubMed ID: 24597702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
    Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
    Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated in vitro release testing method for naltrexone loaded PLGA microspheres.
    Andhariya JV; Choi S; Wang Y; Zou Y; Burgess DJ; Shen J
    Int J Pharm; 2017 Mar; 520(1-2):79-85. PubMed ID: 28153651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y; Chen D; Qiao M; Lu Z; Hu H
    J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopentin loaded microsphere preparation by w/o/w emulsion technique: in vitro/ex vivo evaluation.
    Conti B; Panico M; Ventura CA; Giunchedi P; Puglisi G
    J Microencapsul; 1997; 14(3):303-10. PubMed ID: 9147280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol as a processing co-solvent on the PLGA microsphere characteristics.
    Rawat A; Burgess DJ
    Int J Pharm; 2010 Jul; 394(1-2):99-105. PubMed ID: 20472046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated temperature accelerated release testing of PLGA microspheres.
    Zolnik BS; Leary PE; Burgess DJ
    J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV; Couet W; Olivier JC
    Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo pharmacodynamic evaluation of thymopentin loaded poly(lactide acid)/poly(lactide-co-glycolide acid) implants.
    Wei G; Jin L; Xu L; Liu Y; Lu W
    Int J Pharm; 2010 Oct; 398(1-2):123-9. PubMed ID: 20674730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
    Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
    Yang Y; Gao Y; Mei X
    Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism.
    Tomic I; Vidis-Millward A; Mueller-Zsigmondy M; Cardot JM
    Int J Pharm; 2016 May; 505(1-2):42-51. PubMed ID: 27025293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.